The relief and recovery effort in Puerto Rico continues to pose unique difficulties for aid organizations and businesses alike: the destruction of the island's electrical grid and communications infrastructure has made routine tasks much more difficult, adding friction to every point of the shoreside supply chain.
For decades, Chinese patients have struggled to gain access to cutting-edge medicines thanks to bureaucratic delays that have hamstrung drug development. Now a sweeping government overhaul of drug approvals is poised to change that.
The industrial scandal engulfing Kobe Steel Ltd. began to reverberate overseas as Japan's third-biggest steelmaker said its staff falsified data about the strength and durability of some aluminum and copper products used in planes, trains and potentially a space rocket.
The EPA is improving access to the Water Discharge Monitoring Report (DMR) Pollutant Loading Tool; the tool allows users to determine who is discharging water pollutant, what (and how much) pollutants they are discharging, and where they are discharging.
The government must start enforcing new legislation requiring companies to disclose slavery and trafficking risks in their supply chains, say anti-slavery campaigners.
Amazon.com must pay nearly $300m in back taxes to Luxembourg, European authorities say after concluding that the tech giant had benefited from an illegal tax arrangement dating to 2003.
Senate Democrats, emboldened by the GOP's failure to unilaterally pass a health-care bill, are launching an effort to win bipartisan support for the investment of $500bn in taxpayer dollars in infrastructure improvements.
Big pharmaceutical companies including Pfizer and Amerisource Bergen in the U.S. could use blockchain technology to verify the authenticity of their drugs.
